Targeted delivery of microRNA 146b mimic to hepatocytes by lactosylated PDMAEMA nanoparticles for the treatment of NAFLD. (5th November 2018)
- Record Type:
- Journal Article
- Title:
- Targeted delivery of microRNA 146b mimic to hepatocytes by lactosylated PDMAEMA nanoparticles for the treatment of NAFLD. (5th November 2018)
- Main Title:
- Targeted delivery of microRNA 146b mimic to hepatocytes by lactosylated PDMAEMA nanoparticles for the treatment of NAFLD
- Authors:
- He, Shuying
Guo, Weihong
Deng, Feihong
Chen, Kequan
Jiang, Yonghong
Dong, Minyu
Peng, Liang
Chen, Xueqing - Abstract:
- Abstract: Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide, and precision therapeutic will be a benefit for the NAFLD regression. In this study, we observed low microRNA 146 b (miR-146 b) expression in NAFLD mice model induced by methionine–choline-deficient diet (MCD) compared with control group. Furthermore, miR-146b −/− mice induced MCD exhibited severe liver steatosis and hepatitis. A bio-distribution study showed that novel Lactosylated PDMAEMA nanoparticles effectively targeted hepatocytes Lac-PDMAEMA. We coupled miR-146b mimic with Lac-PDMAEMA and then were administrated to NAFLD mice model, which could obviously alleviate the hepatic steatosis. Lac-PDMAEMA effectively delivered miR-146b mimic to hepatocytes with a ∼8-fold upregulation of miR-146b mimic targeting MyD88 and IRAK1, and in turn suppressed the expression of PPARγ. Meanwhile, TNF-α and IL-6 mRNA levels were decreased after administration of Lac-PDMAEMA/miR-146b mimic. So, we made a conclusion that targeted delivering miR-146b mimic to the hepatocytes by, coupling Lac-PDMAEMA nanoparticles could effectively alleviate the hepatic steatosis in NAFLD mice, which maybe bring a new and effective way to intervene and therapy the NAFLD. Graphical Abstract:
- Is Part Of:
- Artificial cells, nanomedicine, and biotechnology. Volume 46(2018)Supplement 2
- Journal:
- Artificial cells, nanomedicine, and biotechnology
- Issue:
- Volume 46(2018)Supplement 2
- Issue Display:
- Volume 46, Issue 2 (2018)
- Year:
- 2018
- Volume:
- 46
- Issue:
- 2
- Issue Sort Value:
- 2018-0046-0002-0000
- Page Start:
- 217
- Page End:
- 228
- Publication Date:
- 2018-11-05
- Subjects:
- Non-alcoholic fatty liver disease -- miR-146b -- nanoparticles -- lac-PDMAEMA -- hepatocyte
Artificial cells -- Periodicals
Nanotechnology -- Periodicals
Blood substitutes -- Periodicals
Tissue engineering -- Periodicals
Molecules -- Periodicals
Biotechnology -- Periodicals
615.39 - Journal URLs:
- http://informahealthcare.com/loi/abb?open=2012#id_2012 ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/21691401.2018.1453830 ↗
- Languages:
- English
- ISSNs:
- 2169-1401
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18794.xml